The ability of pro-inflammatory mediators, such as TNFα, interleukin-1, and platelet-derived growth factor, to enhance OPG expression and production in vascular cells, may explain the association between OPG concentrations and cardiovascular diseases [36]. The gene discussed is TNFRSF11B; the disease is cardiovascular disorder.